Cargando…
Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis
Extensive research over the last decade has resulted in a number of highly potent tubulin polymerization inhibitors acting either as microtubule stabilizing agents (MSAs) or microtubule destabilizing agents (MDAs). These inhibitors have potent cytotoxicity against a broad spectrum of human tumor cel...
Autores principales: | Banerjee, Souvik, Hwang, Dong-Jin, Li, Wei, Miller, Duane D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272853/ https://www.ncbi.nlm.nih.gov/pubmed/27827858 http://dx.doi.org/10.3390/molecules21111468 |
Ejemplares similares
-
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
por: Chen, Hao, et al.
Publicado: (2017) -
Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting
por: Garg, Unnati, et al.
Publicado: (2019) -
Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents
por: Cesca, Marta, et al.
Publicado: (2013) -
Tubulin and Tubulin Posttranslational Modifications in Alzheimer’s Disease and Vascular Dementia
por: Santiago-Mujika, Estibaliz, et al.
Publicado: (2021) -
The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
por: Cui, Hongmei, et al.
Publicado: (2021)